With the realization of the ICH's goal of having Europe, Japan, and the United States share both clinical and non-clinical study data, new drug development has become a global undertaking requiring transnational interaction.

Since its foundation, MedicaLingual's mission has been to facilitate this interaction by helping pharmaceutical companies reduce their translation and quality management workload.

MedicaLingual places a priority on continually improving its skill and services, and is committed to fully understanding and effectively supporting your day-to-day efforts to promptly provide outstanding pharmaceuticals for clinical practice and promote their proper use.